HYPERION DEFI, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HYPERION DEFI, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $12.35M, a 13.43% increase year-over-year.
- HYPERION DEFI, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $1.89M.
- HYPERION DEFI, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $10.89M.
- HYPERION DEFI, INC. stock issued during period, value, new issues for the quarter ending 2022-03-31 was $14.90M.
- HYPERION DEFI, INC. stock issued during period, value, new issues for fiscal 2024 was $17.01M, a 56.27% increase from fiscal 2023.
- HYPERION DEFI, INC. stock issued during period, value, new issues for fiscal 2023 was $10.89M.
- HYPERION DEFI, INC. stock issued during period, value, new issues for fiscal 2017 was $6.37M, a 53.76% increase from fiscal 2016.
- HYPERION DEFI, INC. stock issued during period, value, new issues for fiscal 2016 was $4.14M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $17.01M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $12.35M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $1.89M 10-Q · filed 2024-11-12 | |
| 2023-12-31 | $10.89M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $10.89M 10-Q · filed 2024-11-12 | |
| 2022-03-31 | $14.90M 10-Q · filed 2023-11-13 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | |
| 2018-03-31 | $27.30M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $6.37M 10-K · filed 2019-03-27 | |
| 2016-12-31 | $4.14M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |